This product was not featured by Product Hunt yet. It will not be visible on their landing page and won't be ranked (cannot win product of the day regardless of upvotes).
OralInsulin MCP
Evidence-backed oral insulin intelligence for agents
OralInsulin MCP gives AI agents and human decision-makers a structured, source-backed view of the oral and oromucosal insulin landscape. It tracks clinical programs, market estimates, regulatory developments, manufacturers, partnerships and qualified relationship signals through MCP tools and a human-facing site. Built to help researchers, companies, investors and healthcare organizations evaluate evidence, compare claims and connect. Ask it anything: GPT-6 Astra answers by querying the same MCP
Diabetes is already a $1 trillion annual healthcare problem.
The International Diabetes Federation estimates that 589 million adults were living with diabetes in 2024, including 252 million who were undiagnosed. Diabetes caused an estimated 3.4 million deaths and accounted for approximately $1.015 trillion in global health expenditure that year. By 2050, the affected adult population is projected to reach 853 million.
Those figures describe the overall disease burden, not the addressable market for oral insulin. But within that enormous system, people who require insulin still depend primarily on injections or pumps. Developing a reliable oral alternative has remained difficult because insulin is vulnerable to degradation and inconsistent absorption through the gastrointestinal tract.
Oromucosal delivery presents a different possibility: absorption through the oral mucosa, potentially avoiding gastrointestinal transit. That promise remains investigational and must be demonstrated through product-specific human pharmacokinetic, pharmacodynamic, safety and efficacy evidence.
We built OralInsulin MCP because the evidence needed to evaluate and advance that opportunity is fragmented across clinical registries, regulatory databases, scientific publications, patents, company disclosures and market reports. Even “oral insulin” frequently combines swallowed, buccal, sublingual and immunotherapy programs with fundamentally different mechanisms.
The MCP gives agents and humans a shared, source-backed evidence layer. It tracks competing programs, reconciles conflicting market estimates, distinguishes verified relationships from passive activity, and gives researchers, companies, healthcare organizations, investors and potential partners a way to discover the opportunity and connect.
This is a pre-launch research and partnership network, not an approved treatment or medical advice. The goal is to make the problem, evidence and people capable of solving it easier to find.
Source: [IDF Diabetes Atlas, 11th edition global factsheet](https://media.idf.org/media/uplo...)
No comment highlights available yet. Please check back later!
About OralInsulin MCP on Product Hunt
“Evidence-backed oral insulin intelligence for agents”
OralInsulin MCP was submitted on Product Hunt and earned 0 upvotes and 1 comments, placing #32 on the daily leaderboard. OralInsulin MCP gives AI agents and human decision-makers a structured, source-backed view of the oral and oromucosal insulin landscape. It tracks clinical programs, market estimates, regulatory developments, manufacturers, partnerships and qualified relationship signals through MCP tools and a human-facing site. Built to help researchers, companies, investors and healthcare organizations evaluate evidence, compare claims and connect. Ask it anything: GPT-6 Astra answers by querying the same MCP
OralInsulin MCP was featured in Artificial Intelligence (479.1k followers), Medical (3.5k followers), Health (6.9k followers) and OpenAI Day (39 followers) on Product Hunt. Together, these topics include over 134.2k products, making this a competitive space to launch in.
Who hunted OralInsulin MCP?
OralInsulin MCP was hunted by Lorenzo Carver. A “hunter” on Product Hunt is the community member who submits a product to the platform — uploading the images, the link, and tagging the makers behind it. Hunters typically write the first comment explaining why a product is worth attention, and their followers are notified the moment they post. Around 79% of featured launches on Product Hunt are self-hunted by their makers, but a well-known hunter still acts as a signal of quality to the rest of the community. See the full all-time top hunters leaderboard to discover who is shaping the Product Hunt ecosystem.
Want to see how OralInsulin MCP stacked up against nearby launches in real time? Check out the live launch dashboard for upvote speed charts, proximity comparisons, and more analytics.
Lorenzo Carver